Cite
HARVARD Citation
Smith, G. et al. (2021). Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. Open forum infectious diseases. p. . [Online].